As part of the Investing News Network’s (INN) coverage of the Benzinga Cannabis Capital Conference in Toronto, here are highlights from interviews done on the show floor.

Read below to find out what some of the event participants had to say about critical issues in the overall marijuana space, as well as their companies’ upcoming catalysts.


If you missed the show, don’t forget to also check out our full report on the event.

1. KushCo discusses uplisting potential

Jason Vegotsky, chief revenue officer of KushCo Holdings (OTCQB:KSHB), explained to INN the reasons the cannabis packaging company has increased its revenue projections for the 2019 fiscal year.

Previous guidance had KushCo’s revenue pegged between US$110 million and US$120 million. However, based on its performance during the second half of the fiscal year, the company has the confidence to raise its guidance, Vegotsky told INN.

When asked about the possibility and timing on uplisting to a more senior exchange such as the NASDAQ or New York Stock Exchange (NYSE), the executive said the company is “doing everything in [its] power” to achieve it.

“If anybody can uplist, we certainly have a good opportunity to do so,” Vegotsky said.

Since KushCo doesn’t interact directly with marijuana cultivation, the company has a cleaner path to a senior listing in the US.

“It’s a key initiative for us; it’s something that we think we can do and is something that, as the NASDAQ and NYSE get more and more comfortable with the space and more regulation comes into the space, is going to get easier and easier for them to get over the hump,” he said.

In April, KushCo announced it would restate its financial information for the 2018 and 2017 fiscal years because of an accounting error, which Vegotsky categorized as “highly technical.”

The executive added that investors were understanding about the situation once the issue was found and addressed by KushCo.

2. Vireo Health explains selective strategy

Vireo Health International (CSE:VREO) reached its listing on the Canadian Securities Exchange (CSE) on March 20.

Since the public launch of the multi-state operator (MSO), which touts itself as a science-focused company, its shares have risen 8 percent in value for a price of C$5.40.

Kyle Kingsley, founder and CEO of the MSO, told INN the company follows a very selective strategy for its acquisition plans in the US, with a focus on markets with limited licenses.

“We feel Vireo is uniquely positioned to acquire additional licenses via these merit-based processes in conservative states,” Kingsley said.

The executive added that the company is eyeing potential entries into states such as Missouri, Georgia and Utah.

Kingsley said he expects to see movement with two critical bills designed to protect the US marijuana industry. First, he said the most likely outcome is for the SAFE Banking Act to pass.

This bill, if approved, would grant state-level banking protections to marijuana operations in legal states.

“I’m fairly confident that the individual state-based markets are going to be very meaningful for quite some time, at least the next three to five years, independent of the STATES Act being passed,” he said.

3. Innovation Shares talks ETF launch

Lastly, INN caught up with Matt Markiewicz, managing director of Innovation Shares, to talk about the state of the cannabis exchange-traded funds (ETFs) available to investors in the US.

Due to listing limitations, MSOs have not made a splash in many funds in the US. However, in Canada two new funds were launched recently with the direct intention to seek the US opportunity.

Markiewicz said he views the move from the new Canadian funds as “extremely opportunistic” given the “inherent advantage” from the Canadian public markets.

Both of these new funds, the Evolve US Marijuana ETF (NEO:USMJ) and the Horizons US Marijuana Index ETF (NEO:HMUS), are listed on the NEO Exchange, an emerging exchange in Toronto that does not block trading from US marijuana operations despite the federal illegality of the drug.

Markiewicz expects to see interest in the US cannabis space grow from both existing companies and also from emerging merger and acquisition activity, such as the recent agreement between Canopy Growth (NYSE:CGC,TSX:WEED) and Acreage Holdings (CSE:ACGR.U,OTCQX:ACRGF).

“[The new Canadian funds] should be successful given that the interest for the US cannabis space seems to be increasing by the day,” he said.

Innovation Shares is in the process of launching a public ETF with marijuana stocks. Markiewicz said there is a lot of room available for competition in terms of current offerings for marijuana ETFs for US investors.

According to Markiewicz, the firm filed for its fund in November 2018 and is currently in review with the US Securities and Exchange Commission. No official launch date has been given so far.

In April, AdvisorShares launched the AdvisorShares Pure Cannabis ETF (ARCA:YOLO), offering cannabis exposure to US investors and active management.

“We’re really excited by the opportunity to engage both retail and institutional investors as they explore various options to get access to the growing space of cannabis investing” Markiewicz said.

With files from Olivia Da Silva.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Acreage Holdings is a client of the Investing News Network. This article is not paid-for content.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less